It's reasonable to assume that any changes in β-catenin expression, such as its relocation from the cell membrane to the cytoplasm and nucleus, could compromise the integrity of the E-cadherin/β-catenin complex, leading to weaker cell-to-cell adhesion in cancer cells [21]. This evidence concerns the gene CDH1 and cancer.